New study aims to match kidney cancer patients to best first therapy
NCT ID NCT05782400
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study looks at 100 people with advanced kidney cancer to find clues in their blood, tumor tissue, and CT scans that could predict which first-line treatment works best. Researchers will use advanced computer analysis to combine these clues. The goal is to create a tool that helps doctors choose the right therapy for each patient, improving outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CLEAR CELL RENAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istituto Tumori
Milan, Mi, 20156, Italy
Conditions
Explore the condition pages connected to this study.